1. Gottlieb, T. & Oren, M. p53 in growth control and neoplasia.Biochim. Biophys. Acta1287, 77–102 (1996).

   PubMed  Google Scholar 

2. Shen, Y. & Shenk, T. E. Viruses and apoptosis.Curr. Opin. Gene. Dev.5, 105–111 (1995).

   Article CAS  Google Scholar 

3. Picksley, S. M. & Lane, D. P. The p53–mdm2 autoregulatory feedback loop—a paradigm for the regulation of growth control by p53?Bioessays15, 689–690 (1993).

   Article CAS  Google Scholar 

4. Chen, J. D., Lin, J. Y. & Levine, A. J. Regulation of transcription functions of the p53 tumor suppressor by themdm-2 oncogene.Mol. Med.1, 141–142 (1995).

   Google Scholar 

5. Chen, C. Y.et al. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.Proc. Natl Acad. Sc. USA91, 2684–2688 (1994).

   Article ADS CAS  Google Scholar 

6. Haupt, Y., Barak, Y. & Oren, M. Cell type-specific inhibition of p53-mediated apoptosis by mdm2.EMBO J.15, 1596–1606 (1996).

   Article CAS  Google Scholar 

7. Chen, J. D., Wu, X., Lin, J. Y. & Levine, A. J. mdm-2 inhibitis the Gl arrest and apoptosis functions of the p53 tumor suppressor protein.Mol. Cell. Biol.16, 2445–2452 (1996).

   Article CAS  Google Scholar 

8. Perry, M. E., Piette, J., Zawadzki, J. A., Harvey, D. & Levine, A. J. The mdm-2 gene is induced in response to UV light in a p53-dependent manner.Proc. Natl Acad. Sci. USA90, 11623–11627(1993).

   Article ADS CAS  Google Scholar 

9. Barak, Y., Gottlieb, E., Juven-Gershon, T. & Oren, M. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.Genes Dev.8, 1739–1749 (1994).

   Article CAS  Google Scholar 

10. Lin, J. Y., Chen, J. D., Elenbaas, B. & Levine, A. J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes Dev.8, 1235–1246 (1994).

    Article CAS  Google Scholar 

11. Hinds, P. W.et al. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells-a comparison of the hot spot mutant phenotype.Cell Growth Diff.1, 571–580 (1990).

    CAS PubMed  Google Scholar 

12. Unger, T., Nau, M. M., Segal, S. & Minna, J. D. p53—a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.EMBO J.11, 1383–1390 (1992).

    Article CAS  Google Scholar 

13. Oren, M., Reich, N. C. & Levine, A. J. Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny.Mol. Cell. Biol.2, 443–449 (1982).

    Article CAS  Google Scholar 

14. Yonish-Rouach, E.et al. Induction of apoptosis by transiently transfected metabolically stable wt p53 is transformed cell lines.Cell Death Differ.1, 39–47 (1994).

    CAS PubMed  Google Scholar 

15. Palombella, V. J., Rando, O. J., Goldberg, A. L. & Maniatis, T. The ubiquitin-proteasome pathway is required for processing the NF-κBl precursor protein and the activation of NF-κB.Cell78, 773–785 (1994).

    Article CAS  Google Scholar 

16. Maki, C. J., Huibregtse, J. M. & Howley, P. M.In vivo ubiquitination and proteasome-mediated degradation of p53.Cancer Res.56, 2649–2654 (1996).

    CAS PubMed  Google Scholar 

17. Kubbutat, M. H. & Vousden, K. H. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability.Mol. Cell. Biol.17, 460–468 (1997).

    Article CAS  Google Scholar 

18. Gottlieb, E., Lindner, S. & Oren, M. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells.Cell Growth Diff.7, 301–310 (1996).

    CAS PubMed  Google Scholar 

19. Lane, D. P. The regulation of p53 function: Steiner award lecture.Int. J. Cancer57, 623–627 (1994).

    Article CAS  Google Scholar 

20. Bartek, J., Iggo, R., Gannon, J. & Lane, D. P. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.Oncogene5, 893–899 (1990).

    CAS PubMed  Google Scholar 

21. Martin, K.et al. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.Nature575, 691–694 (1995).

    Article ADS  Google Scholar 

22. Xiao, Z. X.et al. Interaction between the retinoblastoma protein and the oncoprotein Mdm2.Nature375,694–698 (1995).

    Article ADS CAS  Google Scholar 

23. Momand, J. & Zambetti, G. P. Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics.Oncogene12, 2279–2289 (1996).

    CAS PubMed  Google Scholar 

24. Kastan, M. B., Onyekwere, O., Sindransky, D., Vogelstein, B. & Craig, R. W. Participation of p53 protein in the cellular response to DNA damage.Cancer Res.51, 6304–6311 (1991).

    CAS  Google Scholar 

25. Fiscella, M.et al. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.Oncogene8, 1519–1528 (1993).

    CAS PubMed  Google Scholar 

26. Scheffner, M., Huibregtse, J. M., Vierstra, R. D. & Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.Cell75, 495–505 (1993).

    Article CAS  Google Scholar 

27. Otto, A. & Deppert, W. Upregulation of mdm-2 expression in Meth A tumor cells tolerating wild-type p53.Oncogene8, 2591–2603 (1993).

    CAS PubMed  Google Scholar 

28. Jones, S. N., Roe, A. E., Donehower, L. A. & Bradley, A. Rescue of embryonic lethality in mdm2-deficient mice by absence of p53.Nature378, 206–208 (1995).

    Article ADS CAS  Google Scholar 

29. Monies de Oca Luna, R., Wagner, D. S. & Lozano, G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.Nature378, 203–206 (1995).

    Article ADS  Google Scholar 

Download references